Sign in

You're signed outSign in or to get full access.

Suvretta Capital Management, LLC

CIK:0001569064
Hedge Fund
$5B AUM
98 holdings
New York, NY, United States
Founded:2012
25 employees
Latest filing:Jun 30, 2025

Suvretta Capital Management, LLC is a hedge fund headquartered in New York, NY, United States. The firm was founded in 2012 and employs approximately 25 professionals, over half of whom are investment personnel. Suvretta manages assets for institutional investors and high-net-worth individuals, focusing on public equities.

Investment Strategy

Suvretta Capital Management, LLC uses a fundamentals-driven, long/short equity investment strategy focused primarily on public equity markets. The firm employs deep research to identify attractive opportunities on both the long and short sides, targeting businesses with strong fundamentals while hedging risk through short positions. Their investment philosophy emphasizes capital preservation, risk management, and generating risk-adjusted absolute returns across changing market conditions.

Latest 13F Filing Activity

Suvretta Capital Management, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 94 equity positions and 3 options positions with a total 13F market value of $3B. The fund increased holdings in Coca Cola Co., Dicks Sporting Goods Inc., Nvidia Corporation among other positions. Suvretta Capital Management, LLC reduced exposure to Intra-cellular Therapies Inc., Insmed Inc., Biohaven LTD among others.

Top Buys
K
KOCOCA COLA CO
+$57.5M
D
DKSDICKS SPORTING GOODS INC
+$51.5M
N
NVDANVIDIA CORPORATION
+$40.7M
G
GEGE AEROSPACE
+$39.7M
G
GEHCGE HEALTHCARE TECHNOLOGIES I
+$39.4M
Top Sells
I
ITCIINTRA-CELLULAR THERAPIES INC
-$92.5M
I
INSMINSMED INC
-$89.8M
B
BHVNBIOHAVEN LTD
-$55.8M
C
CMGCHIPOTLE MEXICAN GRILL INC
-$27.1M
U
UALUNITED AIRLS HLDGS INC
-$24.5M

Top Holdings

A
ARQTARCUTIS BIOTHERAPEUTICS INC
+4.9%$161.7M
E
ETNB89BIO INC
+4.2%$139.5M
L
LEGNLEGEND BIOTECH CORP
+4.0%$133.9M
M
METAMETA PLATFORMS INC
+3.8%$125.4M
B
BNTCBENITEC BIOPHARMA INC
+3.5%$115.6M

Equity Positions (94)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
ARCUTIS BIOTHERAPEUTICS INC4.88%$161.7M11,535,582$6.10$14.02-$16.9M
89BIO INC4.21%$139.5M14,210,000$9.89$9.82+$35.3M
LEGEND BIOTECH CORP4.04%$133.9M3,774,009$32.65$35.49+$6.7M
META PLATFORMS INC3.78%$125.4M169,845$201.80$738.09+$21.8M
BENITEC BIOPHARMA INC3.48%$115.6M9,876,506$9.17$11.70-$12.9M

Options Positions (3)

TickerSecurityActionTypeNotional ValueContractsUnderlying PricePremium PaidChange (Contracts)Change (Value)
SPDR S&P 500 ETF TRBought
Put
$432.5M7,000$617.85$569.23+3,000+$208.7M
ISHARES TRNew
Put
$151.6M7,025$215.79$215.79+7,025+$151.6M
NVIDIA CORPORATIONNew
Call
$79.0M5,000$157.99$157.99+5,000+$79.0M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+39.0%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+7.5%
SEMICONDUCTORS & RELATED DEVICES
+6.5%
SERVICES-PREPACKAGED SOFTWARE
+4.9%
BEVERAGES
+4.1%

Investment Team (13)

NameRoleLocationLinkedIn
A
Aleksandr Rabodzey
Managing DirectorMenlo Park, CA , United States
Amanda Birdsey-Benson
Amanda Birdsey-Benson
AnalystUnited States
David Friedman
David Friedman
Managing DirectorNew York, NY , United States
H
Harris Galitz
Managing DirectorNew York, NY , United States
Kenneth Atkins
Kenneth Atkins
AnalystNew York, NY , United States
K
Kishen Mehta
Portfolio ManagerNew York, NY , United States
Thomas Wilkes
Thomas Wilkes
Managing Director and Consumer Sector HeadNew York, NY , United States
Beth Williams
Beth Williams
Managing PartnersNew York, NY , United States
D
David F.
Analyst
Jared Bauer
Jared Bauer
AnalystNew York, NY , United States
Showing 1-10 of 13 team members